Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | FCGR3B | O75015 | 1/20 | 0.34 |
| ▸ | FCGR1A | P12314 | 1/20 | 0.34 |
| ▸ | FCGR2A | P12318 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6272263 | 0.88 | ADRA2B (0.44) | ADRA2BFCGR3BFCGR1AFCGR2APRSS1 | |
| SCHEMBL6271319 | 0.84 | FCGR3B (0.40) | ADRA2BFCGR3BFCGR1AFCGR2AALDH1A1 | |
| SCHEMBL6272151 | 0.82 | CA12 (0.41) | FCGR3BFCGR1AFCGR2APRSS1ALDH1A1 | |
| SCHEMBL6657713 | 0.81 | KMT2A (0.37) | FCGR3BFCGR1AFCGR2APRSS1KMT2A | |
| SCHEMBL7816016 | 0.81 | ADRA2B (0.40) | ADRA2BFCGR3BFCGR1AFCGR2APRSS1 | |
| SCHEMBL6739725 | 0.81 | ADRA2B (0.37) | ADRA2BFCGR3BFCGR1AFCGR2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL6271307 | 0.79 | ADRA2B (0.36) | ADRA2BFCGR3BFCGR1AFCGR2AEGFR | |
| SCHEMBL6739060 | 0.78 | ADRA2B (0.38) | ADRA2BFCGR3BFCGR1AFCGR2AEGFR | |
| SCHEMBL6266435 | 0.78 | ADRA2B (0.41) | ADRA2BALDH1A1EGFRKMT2AMAPT | |
| SCHEMBL6269476 | 0.78 | ADRA2B (0.33) | ADRA2BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1116711-B1 | 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds | WELLA AG (DE) | 2005-12-14 | — | — | EP | claimed |
| US-6800097-B2 | FOR DYEING KERATIN FIBERS; HAIR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-10-05 | — | — | US | claimed |
| US-6780998-B2 | DEVELOPER-COUPLER SUBSTANCE COMBINATION HAIR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | claimed |
| US-20030070241-A1 | Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2003-04-17 | — | — | US | claimed |
| US-20020189033-A1 | Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2002-12-19 | — | — | US | claimed |
| US-6436152-B1 | Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA AKTIENGESELLSCHAFT (DE) | 2002-08-20 | — | — | US | claimed |
| EP-1116711-A2 | 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds | Wella Aktiengesellschaft (DE) | 2001-07-18 | — | — | EP | claimed |
| EP-1116711-B1 | 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds | WELLA AG (DE) | 2005-12-14 | — | — | EP | disclosed |
| US-6800097-B2 | FOR DYEING KERATIN FIBERS; HAIR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-10-05 | — | — | US | disclosed |
| US-6780998-B2 | DEVELOPER-COUPLER SUBSTANCE COMBINATION HAIR DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | disclosed |
| US-20030070241-A1 | Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2003-04-17 | — | — | US | disclosed |
| US-20020189033-A1 | Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2002-12-19 | — | — | US | disclosed |
| US-6436152-B1 | Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same | WELLA AKTIENGESELLSCHAFT (DE) | 2002-08-20 | — | — | US | disclosed |
| EP-1116711-A2 | 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds | Wella Aktiengesellschaft (DE) | 2001-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020189033-A1 | Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same | DDT, CYP1B1, ALDH7A1 | ADRA2B 1384/4885FCGR3B 4685/4885FCGR1A 4558/4885 |
| US-20030070241-A1 | Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same | DDT, ALDH7A1, DDC | ADRA2B 2238/4885FCGR3B 4861/4885FCGR1A 4809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.